Company
Moderna
- Episodes
- 12
- Share
- 1.3%
- Shows
- 9
- Net sentiment
- −0.75
Up from 0.2% of episodes in the weeks before; net sentiment was +0.57.
Bullish 1Mixed 1Neutral 0Bearish 10
5 weeks
Share of each week's episodes naming it, and net sentiment.
0%2%4%
Sep 21Sep 28Oct 5Oct 12Oct 19
Net sentiment
−10+1
Sep 21Sep 28Oct 5Oct 12Oct 19
The episodes that named it
Why each one was bullish, bearish or in between on Moderna. Longest episodes first.
Bearish 10
- Phase III cancer vaccine data came in below expectations, causing an 18% share drop.Moderna Drama, WSJ Mansion Section, Genetically Engineered Military Dogs | Thomas Wright, Kyle Schiller, Steven Schwartz · TBPN · Oct 23
- Shares rallied on a cancer trial claim the speaker thinks is overhyped and already priced in.Bitcoin Is Just Getting Started, Says Billion Dollar Investor | Moez Kassam · The Pomp Podcast · Oct 20
- Shares fell about 17% after leaked trial data disappointed investors.9AM HOUR: Apple iPhone Duo Hits Stores, Tech Extends Sell-off, Merck CEO "First on CNBC" 10/23/26 · Squawk on the Street · Oct 23
- Shares plunged about 24% amid reports of leaked cancer vaccine trial data.Capital Concerns Hammer the AI Trade 10/22/26 · The Exchange · Oct 22
- Shares tumbled after a data leak, despite results largely in line with expectations.Tech Tumbles In Market Sell-Off… And Moderna’s Meltdown After Data Leak 10/22/26 · CNBC's "Fast Money" · Oct 22
- Stock fell about 18-26% after leaked phase three data showed 42% rather than 49% reduction.Why Moderna Tanked, MSG Employees Duped By Their Boss, The Mansion Section | Diet TBPN · TBPN · Oct 23
Show 4 moreShow fewer
- Shares fell about 17% after leaked data, despite positive cancer vaccine results.OpenAI’s Next Round, SpaceX’s Big Plans, & Reforming the MBA Program 10/23/26 · Squawk Pod · Oct 23
- Shares dropped about 18% after premature trial data failed to match inflated expectations.Why Calling a Democrat a Socialist Isn’t the Insult It Once Was · WSJ What’s News · Oct 23
- Shares lost about 18% after cancer vaccine results fell short of market hopes.AI Fears Rise Again on Wall Street · WSJ What’s News · Oct 22
- Shares fell as much as 26% after leaked vaccine trial results disappointed investors.Tech stocks wobble; Russia and Ukraine exchange attacks, and more · The World in Brief from The Economist · Oct 23
Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.
Briefs like this, for everything you follow.
Ethmos puts research agents on your coverage universe — every debate that touches your names, every executive appearance you'd have missed — and files briefs every morning.
Start free14-day free trial